Is Suki AI profitable?

No profitability figures are public. Suki is privately held, last valued at ~$500M in an October 2024 Series D that raised $70M, with $168M cumulative funding after a January 2025 Zoom Ventures extension. No revenue disclosures exist beyond company traction metrics like 400+ health-system partners as of March 2026.

Could AI replace Suki AI?

Suki's own product already replaces human scribes with AI. The bigger threat is Epic Systems shipping free bundled 'Epic AI Charting' in February 2026, covering 35-42% of the US acute-care hospital market, which could erode Suki's Epic-based customer base and pricing power.

Suki AI is privately held and venture-backed, founded in 2017 by Punit Soni. Investors include Venrock, March Capital, Flare Capital, Hedosophia, and Zoom Ventures, which invested January 30, 2025. No parent company or acquisition has been reported as of mid-2026.

Who is Suki AI's biggest competitor?

Epic Systems poses the largest structural threat, having launched free bundled Epic AI Charting in February 2026 across its 35-42% hospital market share. Among ambient-scribe rivals, Abridge (~30% share, $5.3B valuation) and Nuance Dragon Copilot (~33% KLAS share) lead Suki in market position.

What is Suki AI's current valuation?

Suki AI was valued at approximately $500M following its $70M Series D round on October 10, 2024, led by Hedosophia. A Zoom Ventures extension followed January 30, 2025, bringing cumulative funding to $168M, but no valuation update has been reported since, making the figure over 17 months stale by mid-2026.

Does Suki AI have measurable ROI data for hospitals?

Yes. A KLAS Research independent validation published January 22, 2026 found Suki delivered ~$1,223 average incremental revenue per provider per month across McLeod, FMOL, and Rush health systems, with after-hours documentation time falling 35 to 65 percent.

AI companies and labs · United States

Suki AI

suki.ai ↗

Suki makes an AI voice assistant that writes clinical notes for doctors in real time.

Losing its protection

Assessed 21 July 2026 · Evidence as of 21 July 2026

The structural protection is eroding.

On the recordSince 21 July 2026 · Checkable from H2 2026 · Every call on the record Checkpoint: Epic AI Charting adoption data across Epic's installed base through year end

The call

Suki has real hospitals and real revenue numbers, but Epic just gave every Epic hospital a free version of Suki's product, and Suki hasn't raised money in over a year.

Suki sells software that records what doctors say to patients and automatically writes down the visit notes. It works well enough that 400+ hospitals pay for it and save money. The problem is that Epic, the giant company that makes the software almost all big hospitals already use, just gave away a nearly identical tool for free as part of their package in early 2026, which means Suki can no longer charge hospitals in that category. Suki still has customers using other software systems (like Athena or MEDITECH), but it is smaller and less funded than rivals like Abridge and Nuance Dragon Copilot. The one thing that could save Suki is if Epic's free tool turns out to work badly, or if it stays stuck in the process so long that hospitals stick with Suki instead, but neither looks likely right now.

Why

AI pressure: Epic AI Charting. Epic bundles its own ambient charting AI free into the EHR that 35-42% of US hospitals already run, cutting Suki's reason to exist there. Could AI do the core job? Only partly.

Bigger players: Epic Systems. Epic owns the EHR screen doctors live in all day, so its free charting tool starts every fight already inside the building. Could a giant copy it? Probably.

What protects it. Suki survives on non-Epic hospitals and partner deals like Zoom, Sevocity, and HealthEdge where it gets embedded directly into someone else's workflow.

What would change this call

Epic AI Charting adoption rate across Epic's hospital base through 2027. Shows if Suki's Epic-hospital customers are switching to the free bundled tool.
Suki's next funding round terms (up round, flat, or down round) within 6-9 months. Indicates whether investors still see growth versus stagnation since Jan 2025.
athenahealth or MEDITECH announcing a native ambient scribe feature. Would remove Suki's remaining defensible non-Epic hospital territory.

Key numbers

400+ health system partners (Mar 2026)
$1,223/provider/month revenue lift per KLAS (Jan 2026)
Valuation stuck near $500M since Jan 2025 (Jun 2026)

Named risks

Epic AI Charting bundled free could collapse Suki's pricing power in Epic-based hospitals. Severity: high
Funding round stale since January 2025 while rivals like Abridge raise far larger rounds. Severity: medium
Sector-wide litigation over ambient recording consent (Sharp HealthCare suit, Nov 2025). Severity: medium
Trailing category leaders Abridge and Dragon Copilot in market share and capital. Severity: medium
Payer scrutiny of AI-assisted coding upcoding claims could undercut key ROI pitch. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Epic Systems	losing to	Epic shipped free bundled Epic AI Charting Feb 2026, covering 35-42% of hospital market
Abridge	losing to	Abridge holds ~30% category share and $5.3B valuation vs Suki's stale ~$500M mark (2025-10-21 data)
Nuance Dragon Copilot	contesting	~33% KLAS share with deep native Epic integration, rebranded March 2025
athenahealth	contesting	Current Suki EHR partner, but reportedly developing native 'athenaAmbient' scribe
MEDITECH	contesting	Existing Suki partner EHR; native ambient scribe launch would close Suki's non-Epic niche

Questions people ask

Is Suki AI profitable?: No profitability figures are public. Suki is privately held, last valued at ~$500M in an October 2024 Series D that raised $70M, with $168M cumulative funding after a January 2025 Zoom Ventures extension. No revenue disclosures exist beyond company traction metrics like 400+ health-system partners as of March 2026.
Could AI replace Suki AI?: Suki's own product already replaces human scribes with AI. The bigger threat is Epic Systems shipping free bundled 'Epic AI Charting' in February 2026, covering 35-42% of the US acute-care hospital market, which could erode Suki's Epic-based customer base and pricing power.
Who owns Suki AI?: Suki AI is privately held and venture-backed, founded in 2017 by Punit Soni. Investors include Venrock, March Capital, Flare Capital, Hedosophia, and Zoom Ventures, which invested January 30, 2025. No parent company or acquisition has been reported as of mid-2026.
Who is Suki AI's biggest competitor?: Epic Systems poses the largest structural threat, having launched free bundled Epic AI Charting in February 2026 across its 35-42% hospital market share. Among ambient-scribe rivals, Abridge (~30% share, $5.3B valuation) and Nuance Dragon Copilot (~33% KLAS share) lead Suki in market position.
What is Suki AI's current valuation?: Suki AI was valued at approximately $500M following its $70M Series D round on October 10, 2024, led by Hedosophia. A Zoom Ventures extension followed January 30, 2025, bringing cumulative funding to $168M, but no valuation update has been reported since, making the figure over 17 months stale by mid-2026.
Does Suki AI have measurable ROI data for hospitals?: Yes. A KLAS Research independent validation published January 22, 2026 found Suki delivered ~$1,223 average incremental revenue per provider per month across McLeod, FMOL, and Rush health systems, with after-hours documentation time falling 35 to 65 percent.

Timeline

2026-06-25Sevocity partnership embeds Suki ACI in chart sections, cutting documentation time 76%
2026-06-10Suki Developer Platform marks two years, adds MCP server support for agentic workflows
2026-03-18Optum Real collaboration announced; Suki reports 400+ health-system partners
2026-02-17KLAS Research validates ~$1,223/provider/month incremental revenue from Suki
2026-02Epic Systems ships free bundled Epic AI Charting to initial 7 hospital adopters
2026-01-28HealthEdge and Suki launch ambient AI for payer care management
2025-03-02Wolters Kluwer integrates UpToDate content into Suki Assistant
2025-01-30Zoom Ventures invests; cumulative Suki funding reaches $168M
2024-11-20Suki launches EHR partner program adding MEDENT and Azalea Health
2024-10-10Suki raises $70M Series D led by Hedosophia at ~$500M valuation

Revision history

21 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Safe Superintelligence Inc.Mistral AI Cohere